1-8 of 8
Authors: Jos. H Beijnen
Sort by
Journal Article
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
Semra Palić and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1547–1554, https://doi.org/10.1093/jac/dkae129
Published: 10 May 2024
Journal Article
Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study
Anke E Kip and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 5, May 2021, Pages 1258–1268, https://doi.org/10.1093/jac/dkab013
Published: 02 March 2021
Journal Article
Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa
Semra Palić and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3260–3268, https://doi.org/10.1093/jac/dkaa314
Published: 11 August 2020
Journal Article
Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure–response relationships
Anke E Kip and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 8, August 2018, Pages 2104–2111, https://doi.org/10.1093/jac/dky143
Published: 10 May 2018
Journal Article
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study
Thomas P C Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 11, November 2017, Pages 3131–3140, https://doi.org/10.1093/jac/dkx283
Published: 06 September 2017
Journal Article
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Get access
Thomas P. C. Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 11, November 2012, Pages 2576–2597, https://doi.org/10.1093/jac/dks275
Published: 24 July 2012
Journal Article
Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine
Get access
Thomas P. C. Dorlo and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 8, August 2012, Pages 1996–2004, https://doi.org/10.1093/jac/dks164
Published: 10 May 2012
Journal Article
Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz
Get access
Wiete Kromdijk and others
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 5, May 2012, Pages 1211–1216, https://doi.org/10.1093/jac/dks011
Published: 01 February 2012
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals